Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Klisyri ® (tirbanibulin) – New drug approval
December 15, 2020 - Athenex announced the FDA approval of Klisyri (tirbanibulin), for the topical treatment of actinic keratosis (AK) of the face or scalp.
